VMD VIEMED HEALTHCARE, INC.

Nasdaq viemed.com


$ 6.85 $ 0.08 (1.18 %)    

Wednesday, 22-Oct-2025 11:48:53 EDT
QQQ $ 606.86 $ -3.96 (-0.65 %)
DIA $ 468.02 $ -1.11 (-0.24 %)
SPY $ 669.22 $ -2.71 (-0.4 %)
TLT $ 91.91 $ -0.08 (-0.09 %)
GLD $ 371.67 $ -1.18 (-0.32 %)
$ 6.83
$ 6.78
$ 6.83 x 30
$ 6.85 x 21
$ 6.76 - $ 6.86
$ 5.93 - $ 9.81
108,570
na
264.91M
$ 0.87
$ 18.95
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 03-10-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-06-2024 03-31-2024 10-Q
7 03-06-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-08-2023 03-31-2023 10-Q
11 03-02-2023 12-31-2022 10-K
12 11-01-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 03-07-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-03-2021 03-31-2021 10-Q
19 03-03-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 03-04-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

 viemed-healthcare-raises-fy2025-sales-guidance-from-256000m-265000m-to-271000m-277000m-vs-260550m-est

Viemed Healthcare (NASDAQ:VMD) raises FY2025 sales outlook from $256.000 million-$265.000 million to $271.000 million-$277.000 ...

 viemed-healthcare-q2-eps-008-inline-sales-63056m-miss-63100m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is...

 viemed-healthcare-raises-fy2025-sales-guidance-from-25400m-26500m-to-25600m-26500m-vs-26000m-est

Viemed Healthcare (NASDAQ:VMD) raises FY2025 sales outlook from $254.00 million-$265.00 million to $256.00 million-$265.00 mill...

 viemed-healthcare-q1-eps-006-inline-sales-5913m-miss-6060m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is...

 viemed-healthcare-agrees-to-acquire-lehans-medical-equipment-for-base-purchase-price-of-26m

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acu...

 viemed-healthcare-expects-fy25-net-revenue-of-254m--265m-est-25150m

Adjusted EBITDA for the year ending December 31, 2025 is expected to be in the range of $54 million to $58 million.

 viemed-healthcare-q4-2024-gaap-eps-010-inline-sales-6070m-beat-5995m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is...

 viemed-healthcare-q3-2024-gaap-eps-010-beats-007-estimate-sales-58004m-beat-57150m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.0...

 viemed-healthcare-sees-q4-sales-59700m-60900m-vs-5850m-est

Viemed Healthcare (NASDAQ:VMD) sees Q4 sales of $59.700 million-60.900 million vs $58.50 million estimate.

 viemed-healthcare-q2-2024-adj-eps-004-misses-007-estimate-sales-55000m-beat-53800m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION